Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats.

PLoS One · 2012 · PMC3314679 · PMID 22470485

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The increase mRNA levels of B 2 R, ICAM-1, eNOS and VEGF-A did not reach statistical significance in STZ-diabetic retinae, yet LF22-0542 treatment abolished to control values this trend.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.